AMIX
Autonomix Medical, Inc. Common StockNASDAQHealthcare$0.39-1.99%ClosedMarket Cap: $2.0M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.41
P/S
0.00
EV/EBITDA
0.46
DCF Value
$4.81
FCF Yield
-536.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-228.8%
ROA
-168.8%
ROIC
-205.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $0.00 | $-3.3M | $-0.36 |
| Q2 2026 | $0.00 | $-7.5M | $-1.38 |
| Q1 2026 | $0.00 | $-3.3M | $-1.07 |
| Q4 2025 | $0.00 | $-3.2M | $-1.81 |
Analyst Ratings
View AllMaxim GroupBuy
2026-02-17Trading Activity
Insider Trades
View AllHauser Bradleyofficer: CEO and President
SellWed Aug 13
Capelli Christopherdirector
SellWed Aug 13
KLEMP WALTER Vdirector
SellWed Aug 13
Bisson Loridirector
SellWed Aug 13
Bisson Loridirector
SellWed Aug 13
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
-2.46
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.